• Evaxion will host a conference call and webcast on Aug. 20 at 8:30 a.m. ET to present its Q2 2026 business update and financial results.
• EVX-05, its newly added off-the-shelf glioblastoma vaccine program, will be among the topics discussed.
• Participants can register for the call: https://www.globenewswire.com/Tracker?data=_fl-vORwGqyGklamlQ9PXxs-WyO0vmX0_0_vugzec_9oFo1eU6pjQUkDK1qvaLCplCy6rOc9J7We7yLMwlEK7GbG7ANuqsHvS1Nhi68jHiGLJkLgAVX5yVkiIXaytHa72F807ZfMKSOekidteQb0kjahtexyg5vniTV5imPq9Zs=
• Participants can join the webcast: https://www.globenewswire.com/Tracker?data=_fl-vORwGqyGklamlQ9PX53J5gax5OdhtGLfeW9R2Mc20oQE9SBsgTfMqb68pFMr3duwE9XVisiSknRRTbJu9F8m7PNmKS3HozpyrnZlOqM=

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evaxion A/S published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608170800OMX_____CNEWS_EN_GNW1001257920_en) on August 17, 2026, and is solely responsible for the information contained therein.